Roy M Anderson Selected Research

Neglected Diseases

12/2021	An urgent need: vaccines for neglected tropical diseases.
1/2021	Individual adherence to mass drug administration in neglected tropical disease control: A probability model conditional on past behaviour.
1/2021	Modelling the ability of mass drug administration to interrupt soil-transmitted helminth transmission: Community-based deworming in Kenya as a case study.
11/2020	Patterns of individual non-treatment during multiple rounds of mass drug administration for control of soil-transmitted helminths in the TUMIKIA trial, Kenya: a secondary longitudinal analysis.
1/2016	Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review.
1/2016	Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analyses.
1/2013	How effective is school-based deworming for the community-wide control of soil-transmitted helminths?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roy M Anderson Research Topics

Disease

30	Infections 02/2022 - 10/2005
8	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2017
7	Schistosomiasis (Bilharziasis) 01/2022 - 01/2016
7	Neglected Diseases 12/2021 - 01/2013
4	Filarial Elephantiasis (Lymphatic Filariasis) 01/2021 - 01/2016
4	Disease Progression 01/2020 - 04/2006
3	Trachoma 01/2021 - 01/2016
3	Onchocerciasis 01/2021 - 01/2016
3	Helminthiasis (Helminthiases) 11/2020 - 03/2015
3	Hookworm Infections (Hookworm Infection) 11/2019 - 01/2016
2	Cognitive Dysfunction 01/2020 - 07/2018
2	Virus Diseases (Viral Diseases) 01/2016 - 01/2016
2	Human Influenza (Influenza) 01/2016 - 02/2011
2	Acquired Immunodeficiency Syndrome (AIDS) 04/2006 - 07/2002
2	HIV Infections (HIV Infection) 06/2002 - 03/2002
1	COVID-19 12/2021
1	Breakthrough Infections 12/2021
1	Pneumococcal Infections 11/2020
1	Mixed Dementias 01/2020
1	Atrophy 01/2020
1	Reinfection 01/2019
1	Dementia (Dementias) 01/2018
1	Ascariasis 01/2016
1	Trichuriasis 01/2016
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2007
1	Myocardial Infarction 10/2006
1	Smallpox (Variola) 10/2003
1	Infertility (Sterility) 03/2002

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 12/2021 - 02/2011
6	Pharmaceutical PreparationsIBA 01/2021 - 10/2005
5	Biological ProductsIBA 01/2020 - 10/2003
4	Praziquantel (Biltricide)FDA Link 02/2022 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
3	Amyloid (Amyloid Fibrils)IBA 01/2020 - 07/2018
2	Albendazole (Albenza)FDA Link 01/2019 - 06/2016
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2018
2	AnthelminticsIBA 01/2016 - 01/2016
2	Antiviral Agents (Antivirals)IBA 01/2016 - 02/2011
1	EpitopesIBA 12/2021
1	AntigensIBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 06/2020
1	Apolipoproteins E (ApoE)IBA 01/2018
1	Mebendazole (Anti-Worm)FDA Link 06/2016
1	RNA (Ribonucleic Acid)IBA 10/2005
1	Contraceptive Agents (Contraceptives)IBA 03/2002

Therapy/Procedure

26	Mass Drug Administration 01/2022 - 03/2015
10	Therapeutics 01/2020 - 07/2002
9	Drug Therapy (Chemotherapy) 11/2020 - 01/2016
2	Condoms (Condom) 03/2007 - 06/2002
1	Bathroom Equipment 11/2019
1	Immunotherapy 01/2016
1	Chemoprevention 09/2007